-
Coventry sign Nigeria striker Awoniyi from Forest
-
US-Palestinian says 'terrified' as he returns to property besieged by settlers
-
TripleDart tops $7 million ARR with AI-led growth, reports 50 per cent EBIT margin
-
Amboss Opens Affiliate Program: Earn Recurring Bitcoin Commissions by Growing Bitcoin Payments
-
Bipartisan backlash as Trump scales back US-South Korea drills
-
Netanyahu, Kushner discuss US general for Hamas disarmament: Israeli official
-
'Never seen one like it': German pensioners flee wildfire
-
Scottish FA withdraws support for FIFA boss Infantino
-
Ipswich sign Enciso and Ouattara in double raid on Strasbourg
-
Belgium fire halts short of German border, but not 'contained'
-
UN laments 'unacceptable' toll of 350 aid workers killed in 2025
-
Number one Shi suffers shock first-round exit at badminton worlds
-
Former child star actress Hayden Panettiere dead at 36
-
Kolisi and Nche may miss South Africa Test against New Zealand
-
Pakistan captain Babar Azam doubtful for England opener
-
Trump threatens Oman: latest developments in US-Iran war
-
Pentagon inks Tomahawk deal amid reports of missile shortfall
-
Stocks lower as Hormuz concerns and high oil prices persist
-
Rain halts India push after Dinusha century lifts Sri Lanka
-
Crowds turn out for 'Total Eclipse' singer Bonnie Tyler's funeral
-
Dinusha hits century as Sri Lanka post 284 in first India Test
-
Mali jails junta-critic broadcaster, influencer for seven years
-
Stocks steady as investors weigh US rate path
-
'Nowhere to run': Indonesian quake survivors plead for help
-
Taiwan's leader says government to propose record defence spending for 2027
-
Belgium fire makes 'limited' spread overnight, more help on way
-
Cambridge head slams 'feeding frenzy' over dead academic
-
Vingegaard brings curtain down on season
-
Ebola outbreak now DR Congo's deadliest ever
-
Dickwella, Dinusha hit fifties as Sri Lanka fight back
-
Germany's coalition split over putting climate in constitution
-
Bangladesh Test cricket reboot delivers in style with historic win
-
Ukraine badminton star: 'How can you feel normal when bombs are falling?'
-
Virgin moves closer to launching Eurostar rival in 2030
-
Rain brings respite as Belgium wrestles massive wildfire
-
Indian marble waste dump becomes unlikely tourist attraction
-
Most stocks rise as US data ease rate fears but fuel economic worries
-
Coach says Australia 'let standards slip' in shock Bangladesh loss
-
India take control of Galle Test as Sri Lanka slump to 99-5
-
Hawaii recovery efforts begin as Lala downgraded, moves west
-
Australia's mushroom murderer appeals conviction
-
Food safety crackdown snares Mumbai's famed restaurants
-
The Nigerian fishing community being eaten up by the Atlantic
-
Trump says US scaling back military drills with Seoul hours before start
-
Kushner to meet Netanyahu after talks with Hamas on Gaza plan
-
Nearly 13,000 displaced after deadly Indonesian quake
-
Photos, memories all that remain for Colombia's bereaved after quake
-
Axe hangs over Australian batters after Darwin 'disaster'
-
Sabalenka squeezes out win on sixth match point in Cincinnati
-
Is this cave in Turkey where Homer wrote 'The Odyssey'?
Evolution Devices Announces First Multi-Location Clinical Sale of EvoWalk to Leading Rehabilitation Provider, Advancing National Commercialization
SAN FRANCISCO, CA / ACCESS Newswire / May 12, 2026 / Evolution Devices today announced its first multi-location clinical sale of EvoWalk to Sheltering Arms Institute, a globally recognized leader in physical rehabilitation. The deployment marks a key milestone in Evolution Devices' commercial expansion and underscores growing demand for next-generation mobility solutions in neurorehabilitation.
EvoWalk Device is Worn Just Below the Knee
EvoWalk is designed to improve gait and restore functional walking in individuals with neurological impairments. The system delivers multi-muscle stimulation to enable a more coordinated, natural walking pattern across clinical and home environments, while AI-driven data capture monitors patient progress, adherence, and outcomes to inform clinical decision-making and personalize care.
"The EvoWalk represents a meaningful advancement over our current functional electrical stimulation (FES) systems," said Christina Withers, P.T., D.P.T., P.C.S., senior manager of outpatient therapy services at Sheltering Arms Institute. "Its intuitive design streamlines setup, allowing clinicians to focus more time on patient care and outcomes, while reusable leads and electrodes eliminate per-patient supply costs and improve efficiency."
"The EvoWalk has been a valuable addition for our patient population," said Zach Crump, P.T., D.P.T., N.C.S., locomotor specialist and clinical researcher at Sheltering Arms Institute. "Rapid setup and Bluetooth connectivity improve therapist efficiency, while targeted stimulation for up to six muscle groups supports more effective gait training. Integrated metrics such as step count, gait speed, and cadence provide actionable insights to guide progress."
"This first multi-site clinical sale validates both EvoWalk and the broader need for more effective mobility solutions," said Pierluigi Mantovani, chief executive officer of Evolution Devices. "We are proud to partner with Sheltering Arms Institute, a global leader in neurorehabilitation, as we take the next step toward national commercialization and expanded patient access."
Evolution Devices plans to expand through additional clinical partnerships, broader market access, and continued investment in data-driven insights to support adoption across rehabilitation settings.
About EVOLUTION DEVICES
Evolution Devices is a neurotechnology company advancing mobility solutions for the millions of individuals living with neurological impairments. The company develops innovative, clinically grounded devices designed to restore functional movement, improve gait, and enable greater independence in real-world settings. Evolution Devices' mission is to create accessible and innovative technology to enable anyone, anywhere to receive personalized rehabilitative care, empowering their independence through access to innovative care. For more information, visit www.evolutiondevices.com.
About EVOWALK
EvoWalk is a neurotechnology solution designed to improve gait and restore functional walking for individuals with neurological impairments. Addressing foot drop in addition to calf weakness, knee hyperextension, and hip weakness, it enables a more natural, stable walking pattern in real-world settings. EvoWalk integrates adaptive stimulation with AI-driven data capture to monitor patient progress, adherence, and outcomes - providing actionable insights for clinicians. Lightweight and user-friendly, it supports consistent use and scalable deployment across home and healthcare environments.
Images and Video: LINK
Media Contact
Erica Zeidenberg
Hot Tomato Marketing
925.518.8159
[email protected]
SOURCE: Evolution Devices
View the original press release on ACCESS Newswire
O.Brown--AT
